Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PLC Systems' angina heart laser:

This article was originally published in Clinica

Executive Summary

Japanese regulators have approved for sale PLC Systems' first-generation CO2 heart laser (HL1) device for treating angina. The transmyocardial revascularisation (TMR) product will be distributed in Japan exclusively by Tokyo-based Ktec, which will this year begin the process of establishing the TMR market through hosting educational seminars, attending scientific trade shows and conducting training events. Currently, Ktec has 12 HL1s in Japan, which it purchased in the mid-1990s. Ktec has over 20 sales people in Japan and can sell the HL1 immediately, said Franklin, Massachusetts-based PLC Systems.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel